Glanbia PLC
18 February 2004
WALSH ANNOUNCES €15M INVESTMENT IN WORLD CLASS
INNOVATION CENTRE
The Minister for Agriculture and Food, Mr Joe Walsh TD, today announced plans by
Glanbia plc for the development of a world class Group Innovation Centre to be
located in Kilkenny. The project, supported by Enterprise Ireland and due for
completion in September, will involve an investment of €15m over the next five
years and will create employment opportunities for approximately 30 highly
skilled graduates, some to PHD level.
Making the announcement, Minister Walsh, said: 'Glanbia is to be congratulated
on its plans to develop a world-class innovation centre. The scale of this
investment is a first for the Irish food industry and will significantly
strengthen Glanbia's competitive edge in the international marketplace. The
Group has an established track record in the development of consumer products
and functional foods and a strong R+D capability is essential to its growth
strategy'.
'The Irish food industry in general needs greater investment in research and
product development if it is to move rapidly towards higher value added products
and to respond effectively to market requirements. This was also one of the key
recommendations in the Prospectus report on the strategic development of the
Irish dairy sector and I am very pleased to see Glanbia taking the lead in this
regard,' Minister Walsh added.
Welcoming the announcement by the Minister, Mike Feeney, Executive Director,
Enterprise Ireland said: 'The Glanbia Group Innovation Centre will be a
world-class research and product development facility specialising in
nutritional solutions for both consumers and customers. Enterprise Ireland is
particularly pleased to see Irish food companies committing substantial
investment to high quality Research and Development.'
Commenting on the announcement, John Moloney, Group Managing Director, Glanbia
plc said: 'In line with our commitment to drive growth in high value markets,
the Group is focusing on developing products with a health based functional
foods and nutritional emphasis in both ingredient and consumer form. There is
growing consumer awareness of the link between health and diet and Glanbia as a
food Group is committed to achieving the highest standards of best practice in
relation to science based innovation. This new world-class research and product
development facility is core to this strategy.'
The new Group Innovation Centre will focus on the European market and as such
will complement the Glanbia R+D Centre at Twin Falls, in Idaho, which services
the US nutritional market. It is envisaged that the Innovation Centre will work
closely with Irish and international universities.
18 February 2004
ENDS
Contact Geraldine Kearney, Glanbia plc
Tel 00 353 56 7772200 or Mobile 00 353 87 2319430
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.